Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Sell
26
KAEPY Quote, Financials, Valuation and Earnings
Last price:
$5.87
Seasonality move
:
-0.94%
Day range:
$5.44 - $5.88
52-week range:
$5.10 - $9.30
Dividend yield:
3.03%
P/E ratio:
3.96x
P/S ratio:
0.38x
P/B ratio:
0.60x
Volume:
5.5K
Avg. volume:
12.4K
1-year change:
-11.73%
Market cap:
$10.5B
Revenue:
$28.1B
EPS (TTM):
$1.37
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $29.3B | $29.2B | $25.4B | $29.3B | $28.1B | |
| Revenue Growth (YoY) | -1.8% | -0.43% | -12.92% | 15.21% | -3.88% | |
| Cost of Revenues | $27.4B | $27.8B | $24.5B | $29.7B | $23.1B | |
| Gross Profit | $1.9B | $1.4B | $884.8M | -$385.5M | $5.1B | |
| Gross Profit Margin | 6.5% | 4.71% | 3.48% | -1.32% | 17.96% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -$213.3M | $55.1M | -$94.8M | $6.2M | -$865.6M | |
| Operating Income | $1.9B | $1.4B | $884.8M | -$385.5M | $5.1B | |
| Net Interest Expenses | $219.3M | $204.9M | $169.4M | $164.2M | $159.4M | |
| EBT. Incl. Unusual Items | $1.7B | $1.5B | $1.1B | -$43.2M | $4.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $525.8M | $417.5M | $317.4M | -$197.3M | $1.3B | |
| Net Income to Company | $1.7B | $1.5B | $1.1B | -$43.2M | $4.4B | |
| Minority Interest in Earnings | -$11.1M | -$19.4M | -$34.3M | -$23.2M | -$45.5M | |
| Net Income to Common Excl Extra Items | $1.2B | $1B | $764.6M | $130.9M | $3.1B | |
| Basic EPS (Cont. Ops) | $0.67 | $0.58 | $0.43 | $0.07 | $1.72 | |
| Diluted EPS (Cont. Ops) | $0.67 | $0.58 | $0.43 | $0.07 | $1.72 | |
| Weighted Average Basic Share | $1.8B | $1.8B | $1.8B | $1.8B | $1.8B | |
| Weighted Average Diluted Share | $1.8B | $1.8B | $1.8B | $1.8B | $1.8B | |
| EBITDA | $4.7B | $4.5B | $4.2B | $2.6B | $7.1B | |
| EBIT | $2B | $1.7B | $1.3B | $137M | $4.6B | |
| Revenue (Reported) | $29.3B | $29.2B | $25.4B | $29.3B | $28.1B | |
| Operating Income (Reported) | $1.9B | $1.4B | $884.8M | -$385.5M | $5.1B | |
| Operating Income (Adjusted) | $2B | $1.7B | $1.3B | $137M | $4.6B | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $6.5B | $5.2B | $5.9B | $7B | $6.3B | |
| Revenue Growth (YoY) | -8.83% | -20.27% | 13.99% | 18.91% | -10.38% | |
| Cost of Revenues | $6.1B | $5B | $6.3B | $5.2B | $5.4B | |
| Gross Profit | $451.2M | $197.7M | -$333.4M | $1.9B | $954.3M | |
| Gross Profit Margin | 6.92% | 3.81% | -5.63% | 26.52% | 15.12% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $6M | -- | $3.3M | -- | -- | |
| Operating Income | $451.2M | $197.7M | -$333.4M | $1.9B | $954.3M | |
| Net Interest Expenses | $53.7M | $46.3M | $42.1M | $43.6M | $41.4M | |
| EBT. Incl. Unusual Items | $471.1M | $211.7M | -$128.9M | $2B | $1.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $136.4M | $66.6M | -$52.3M | $528.4M | $314.5M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$827.1K | -$5.6M | -$11.7M | -$19M | -$26.7M | |
| Net Income to Common Excl Extra Items | $333.8M | $139.5M | -$88.2M | $1.4B | $742.7M | |
| Basic EPS (Cont. Ops) | $0.19 | $0.08 | -$0.05 | $0.79 | $0.42 | |
| Diluted EPS (Cont. Ops) | $0.19 | $0.08 | -$0.05 | $0.79 | $0.42 | |
| Weighted Average Basic Share | $1.8B | $1.8B | $1.8B | $1.8B | $1.8B | |
| Weighted Average Diluted Share | $1.8B | $1.8B | $1.8B | $1.8B | $1.8B | |
| EBITDA | $525.1M | $260.6M | -$84.9M | $2B | $1.1B | |
| EBIT | $525.1M | $260.6M | -$84.9M | $2B | $1.1B | |
| Revenue (Reported) | $6.5B | $5.2B | $5.9B | $7B | $6.3B | |
| Operating Income (Reported) | $451.2M | $197.7M | -$333.4M | $1.9B | $954.3M | |
| Operating Income (Adjusted) | $525.1M | $260.6M | -$84.9M | $2B | $1.1B | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $28.7B | $27.8B | $26B | $30.3B | $27.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $26.8B | $26.7B | $25.7B | $28.5B | $23.2B | |
| Gross Profit | $1.8B | $1.1B | $373.7M | $1.9B | $4.2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -$219.3M | -- | -- | $3M | -- | |
| Operating Income | $1.8B | $1.1B | $373.7M | $1.9B | $4.2B | |
| Net Interest Expenses | $215.5M | $197.4M | $165.4M | $165.6M | $157.3M | |
| EBT. Incl. Unusual Items | $1.6B | $1.2B | $795.5M | $2.1B | $3.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $496.6M | $345.5M | $202.7M | $397M | $1.1B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$10.2M | -$24.4M | -$40.1M | -$30.7M | -$53.5M | |
| Net Income to Common Excl Extra Items | $1.1B | $828.5M | $552.7M | $1.7B | $2.5B | |
| Basic EPS (Cont. Ops) | $0.63 | $0.46 | $0.31 | $0.94 | $1.37 | |
| Diluted EPS (Cont. Ops) | $0.63 | $0.46 | $0.31 | $0.94 | $1.37 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $1.9B | $1.4B | $970.4M | $2.3B | $3.8B | |
| EBIT | $1.9B | $1.4B | $970.4M | $2.3B | $3.8B | |
| Revenue (Reported) | $28.7B | $27.8B | $26B | $30.3B | $27.4B | |
| Operating Income (Reported) | $1.8B | $1.1B | $373.7M | $1.9B | $4.2B | |
| Operating Income (Adjusted) | $1.9B | $1.4B | $970.4M | $2.3B | $3.8B | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $6.5B | $5.2B | $5.9B | $7B | $6.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $6.1B | $5B | $6.3B | $5.2B | $5.4B | |
| Gross Profit | $451.2M | $197.7M | -$333.4M | $1.9B | $954.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $6M | -- | $3.3M | -- | -- | |
| Operating Income | $451.2M | $197.7M | -$333.4M | $1.9B | $954.3M | |
| Net Interest Expenses | $53.7M | $46.3M | $42.1M | $43.6M | $41.4M | |
| EBT. Incl. Unusual Items | $471.1M | $211.7M | -$128.9M | $2B | $1.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $136.4M | $66.6M | -$52.3M | $528.4M | $314.5M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$827.1K | -$5.6M | -$11.7M | -$19M | -$26.7M | |
| Net Income to Common Excl Extra Items | $333.8M | $139.5M | -$88.2M | $1.4B | $742.7M | |
| Basic EPS (Cont. Ops) | $0.19 | $0.08 | -$0.05 | $0.79 | $0.42 | |
| Diluted EPS (Cont. Ops) | $0.19 | $0.08 | -$0.05 | $0.79 | $0.42 | |
| Weighted Average Basic Share | $1.8B | $1.8B | $1.8B | $1.8B | $1.8B | |
| Weighted Average Diluted Share | $1.8B | $1.8B | $1.8B | $1.8B | $1.8B | |
| EBITDA | $525.1M | $260.6M | -$84.9M | $2B | $1.1B | |
| EBIT | $525.1M | $260.6M | -$84.9M | $2B | $1.1B | |
| Revenue (Reported) | $6.5B | $5.2B | $5.9B | $7B | $6.3B | |
| Operating Income (Reported) | $451.2M | $197.7M | -$333.4M | $1.9B | $954.3M | |
| Operating Income (Adjusted) | $525.1M | $260.6M | -$84.9M | $2B | $1.1B | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.6B | $2.3B | $3.8B | $2B | $3.3B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.7B | $3B | $2.5B | $3B | $2.6B | |
| Inventory | $1.6B | $1.7B | $1.6B | $1.9B | $1.7B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.7B | $2.2B | $3B | $2.6B | $2B | |
| Total Current Assets | $8.5B | $9.1B | $11B | $9.5B | $9.5B | |
| Property Plant And Equipment | $42.4B | $44.3B | $40.4B | $37B | $32B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $8.4B | $8.4B | $8.1B | $7.9B | $7.2B | |
| Total Assets | $70.4B | $73.2B | $70.9B | $65.9B | $59.7B | |
| Accounts Payable | $1.2B | $1.3B | $1.6B | $1.4B | $1.1B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $9.6B | $9.8B | $9.7B | $7.8B | $7.1B | |
| Total Current Liabilities | $15.6B | $15.9B | $15.6B | $11.9B | $10.6B | |
| Long-Term Debt | $28.9B | $31.2B | $31.9B | $31.4B | $25.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $55.2B | $57.6B | $56.9B | $52B | $44.3B | |
| Common Stock | $4.5B | $4.4B | $4B | $3.7B | $3.2B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $14.8B | $15.3B | $13.6B | $13.4B | $15B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $379M | $371.9M | $376.7M | $382.8M | $397M | |
| Total Equity | $15.2B | $15.6B | $14B | $13.8B | $15.4B | |
| Total Liabilities and Equity | $70.4B | $73.2B | $70.9B | $65.9B | $59.7B | |
| Cash and Short Terms | $2.6B | $2.3B | $3.8B | $2B | $3.3B | |
| Total Debt | $33B | $35.3B | $35.7B | $33.7B | $26.7B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.3B | $1.7B | $2.3B | $2.7B | $2.7B | |
| Short Term Investments | -- | $1B | -- | -- | -- | |
| Accounts Receivable, Net | $3.1B | $2.5B | $2.8B | $2.8B | $3.7B | |
| Inventory | $1.6B | $1.7B | $1.6B | $1.5B | $1.9B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $2.1B | $3.3B | $2.8B | $2.2B | $2.3B | |
| Total Current Assets | $9.2B | $10.1B | $9.5B | $9.1B | $10.6B | |
| Property Plant And Equipment | $43.9B | $43.7B | $34B | $33B | $33.8B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $8.8B | $8.5B | $7B | $7B | $7.8B | |
| Total Assets | $73.4B | $74.1B | $61.2B | $59.5B | $64.1B | |
| Accounts Payable | $1B | $1B | $1.3B | $1.1B | $1.7B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $9.1B | $9.4B | $7.6B | $6.5B | $7.3B | |
| Total Current Liabilities | $15.2B | $16.9B | $13B | $10.1B | $11.1B | |
| Long-Term Debt | $31B | $31.1B | $28.5B | $26.4B | $26.9B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $57B | $58.5B | $49.5B | $44.4B | $46.2B | |
| Common Stock | $4.6B | $4.4B | $3.4B | $3.3B | $3.4B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $386.5M | $384.6M | $365.9M | $375M | $410.4M | |
| Total Equity | $16.4B | $15.6B | $11.6B | $15.2B | $17.8B | |
| Total Liabilities and Equity | $73.4B | $74.1B | $61.2B | $59.5B | $64.1B | |
| Cash and Short Terms | $2.3B | $2.8B | $2.3B | $2.7B | $2.7B | |
| Total Debt | $35.3B | $37B | $32.5B | $27.9B | -- | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.7B | $1.5B | $1.1B | -$43.2M | $4.4B | |
| Depreciation & Amoritzation | $2.7B | $2.8B | $2.9B | $2.4B | $2.5B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $230.5M | -$381M | $172.2M | -$714.7M | $121.3M | |
| Change in Inventories | -- | -- | -$147.4M | -- | -- | |
| Cash From Operations | $4.3B | $3.5B | $3.7B | $948.2M | $8B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$24.3M | -- | $43.3M | -- | -- | |
| Cash From Investing | -$5.3B | -$6.2B | -$4.7B | -$3.1B | -$3B | |
| Dividends Paid (Ex Special Dividend) | -$410.1M | -$420.6M | -$397.2M | -$330.7M | -$309.6M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $14B | $16.8B | $20.2B | $13.3B | $4.2B | |
| Long-Term Debt Repaid | -$11.7B | -$13.2B | -$16.8B | -$12.1B | -$7.2B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $116.4M | -$70.5M | -$86.8M | -$75.5M | -$67.7M | |
| Cash From Financing | $1.9B | $3.1B | $2.8B | $867.2M | -$3.4B | |
| Beginning Cash (CF) | $1.5B | $2.4B | $2.6B | $3.6B | $2.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $894.9M | $321.7M | $1.7B | -$1.3B | $1.6B | |
| Ending Cash (CF) | $2.4B | $2.7B | $4.4B | $2.4B | $3.9B | |
| Levered Free Cash Flow | $4.3B | $3.5B | $3.7B | $948.2M | $8B | |
| Period Ending | 2007-03-31 | 2008-03-31 | 2009-03-31 | 2010-03-31 | 2011-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $35.6M | $185.4M | |
| Depreciation & Amoritzation | -- | -- | -- | $1.5B | $1.2B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -$96.9M | -$168.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | $1.3B | $1.9B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$1.2B | -$1.4B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | $15M | $24M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $2.9B | $2.3B | |
| Long-Term Debt Repaid | -- | -- | -- | -$3.2B | -$2.9B | |
| Repurchase of Common Stock | -- | -- | -- | $883.5K | $205.3M | |
| Other Financing Activities | -- | -- | -- | -$6.1M | -$69.5M | |
| Cash From Financing | -- | -- | -- | -$293M | -$491.4M | |
| Beginning Cash (CF) | -- | -- | -- | $1B | $1.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | $4.1M | $18.8M | |
| Additions / Reductions | -- | -- | -- | -$167.9M | $33.8M | |
| Ending Cash (CF) | -- | -- | -- | $835.5M | $1.1B | |
| Levered Free Cash Flow | -- | -- | -- | $1.3B | $1.9B | |
| Period Ending | 2007-12-31 | 2008-12-31 | 2009-12-31 | 2010-12-31 | 2011-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $2.1B | -- | |
| Depreciation & Amoritzation | -- | -- | -- | $5.7B | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -$92.8M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | $6.5B | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$6.2B | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$603M | -$634.9M | $24M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $16.4B | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$16B | -- | |
| Repurchase of Common Stock | -- | -- | -- | -$204.4M | -- | |
| Other Financing Activities | -- | -- | -- | -$33.4M | -- | |
| Cash From Financing | -- | -- | -- | -$316.4M | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $10M | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | $6.5B | -- | |
| Period Ending | 2021-01-08 | 2022-01-08 | 2023-01-08 | 2024-01-08 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get KAEPY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
KAEPY
Sector
P/E ratio
3.96x
14.34x
PEG ratio
0.09x
0.37x
P/B ratio
0.60x
1.37x
Price / LTM sales
0.38x
1.59x
Growth Metrics
KAEPY
Sector
Revenue growth
-10.38%
0.9%
Earnings growth
-47.24%
2.42%
Revenue (5-year growth)
-1.17%
4.99%
Earnings forecast
--
$0.53
Profitability
KAEPY
Sector
Profitability FY 2023
$5.1B
$1.5B
Return on invested capital
5.64%
3.56%
Return on assets
4.06%
2.54%
Return on equity
20.97%
8.33%
Earnings Date
Last Earnings Date
Jan
8
Next Earnings Date
Jan
8
Estimated Next Earnings Date
Apr
9
Balance Sheet
KAEPY
Sector
Total cash
$2.7B
$428M
Short term investments
--
$145.7M
Total assets
$59.7B
$12.2B
Long term debt
--
$3.1B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
57
NARI alert for Jan 8
Inari Medical [NARI] is up 22.25% over the past day.
Buy
69
UNF alert for Jan 8
UniFirst [UNF] is up 20.59% over the past day.
Sell
31
APOG alert for Jan 8
Apogee Enterprises [APOG] is down 19.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
